Pulsenmore Ltd. Ordinary Shares Cash Flow Conversion Efficiency
Pulsenmore Ltd. Ordinary Shares cash flow conversion efficiency. Based on the latest financial reports, Pulsenmore Ltd. Ordinary Shares (PLSM) has a cash flow conversion efficiency ratio of -0.304x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.10 Million) by net assets ($56.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Pulsenmore Ltd. Ordinary Shares (2019–2025)
Cash flow conversion efficiency of Pulsenmore Ltd. Ordinary Shares from 2019 to 2025. This chart illustrates how Pulsenmore Ltd. Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Pulsenmore Ltd. Ordinary Shares stock price for real-time trading data and today's change.
Pulsenmore Ltd. Ordinary Shares Cash Flow Conversion Ratio Explained
Pulsenmore Ltd. Ordinary Shares cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Pulsenmore Ltd. Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pulsenmore Ltd. Ordinary Shares ranked by their cash flow conversion efficiency. Also see market value of Pulsenmore Ltd. Ordinary Shares for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SL Private Equity
LSE:SLPE
|
-0.001x |
|
Kumulus Vape SA
PA:ALVAP
|
-0.027x |
|
Wong Engineering Corporation Bhd
KLSE:7050
|
-0.012x |
|
MedX Health Corp
V:MDX
|
0.069x |
|
Vakif Menkul Kiymet Yatirim Ortakligi AS
IS:VKFYO
|
-0.031x |
|
RomReal Limited
OL:ROM
|
-0.020x |
|
Perfect Moment Ltd.
NYSE MKT:PMNT
|
2.134x |
|
Crescita Therapeutics Inc
TO:CTX
|
0.027x |
Annual Cash Flow Conversion Efficiency for Pulsenmore Ltd. Ordinary Shares (2019–2025)
The table below shows the annual cash flow conversion efficiency of Pulsenmore Ltd. Ordinary Shares from 2019 to 2025. Review PLSM FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $83.09 Million | $-32.88 Million | -0.396x | -21.06% |
| 2024-12-31 | $103.15 Million | $-33.71 Million | -0.327x | -0.64% |
| 2023-12-31 | $130.70 Million | $-42.45 Million | -0.325x | -142.08% |
| 2022-12-31 | $182.67 Million | $-24.51 Million | -0.134x | +17.85% |
| 2021-12-31 | $159.28 Million | $-26.01 Million | -0.163x | +90.90% |
| 2020-12-31 | $5.28 Million | $-9.47 Million | -1.794x | -85.34% |
| 2019-12-31 | $3.95 Million | $-3.83 Million | -0.968x | -- |
About Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.